


Ask a doctor about a prescription for QUETIAPINE TEVA-RATIO 300 mg PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the User
Quetiapine Teva-ratio 300 mg prolonged-release tablets EFG
quetiapine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.,as it contains important information for you..
Contents of the pack
Quetiapine Teva-ratio contains a substance called quetiapine. It belongs to a group of medicines called antipsychotics. Quetiapine Teva-ratio can be used to treat several diseases, such as:
When Quetiapine Teva-ratio prolonged-release tablets are used to treat major depressive episodes in major depressive disorder, they will be taken in addition to another medication that is being used to treat this disease.
Your doctor may continue to prescribe Quetiapine Teva-ratio even when you are feeling better.
Do not takeQuetiapine Teva-ratio:
If you are in doubt, consult your doctor or pharmacist before taking Quetiapine Teva-ratio.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quetiapine Teva-ratio if:
Tell your doctor immediately if, after taking Quetiapine Teva-ratio, you experience any of the following:
These disorders can be caused by this type of medication.
Tell your doctor as soon as possible if you have:
Suicidal thoughts and worsening of your depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This can increase when you start treatment, as all these medications take time to work, usually around two weeks, but sometimes more. These thoughts can also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of suicidal thoughts and/or suicidal behavior in young adults under 25 years of age with depression.
If at any time you think about harming yourself or committing suicide, contact your doctor or go to a hospital immediately. It may help to tell a family member or close friend that you are depressed and ask them to read this leaflet. You can ask them to tell you if they think your depression is getting worse, or if they are worried about changes in your behavior.
Severe skin reactions (SCARs)
With the use of this medicine, very rare severe skin reactions (SCARs) have been reported, which can be life-threatening or fatal. These are commonly manifested as:
If you develop these symptoms, stop using Quetiapine Teva-ratio and contact your doctor or seek medical attention immediately.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Quetiapine Teva-ratio should not be used in children and adolescents under 18 years of age.
Use of Quetiapine Teva-ratiowith other medicines
Tell your doctor if you are taking, have recently taken, or might take any other medicines.
Do not take Quetiapine Teva-ratio if you are using any of the following medicines:
Tell your doctor if you are using any of the following medicines:
Before stopping any of your medicines, consult your doctor first.
Taking Quetiapine Teva-ratiowith food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine. You should not take Quetiapine Teva-ratio during pregnancy, unless your doctor has told you to. You should not use Quetiapine Teva-ratio if you are breastfeeding.
The following symptoms, which may represent a withdrawal syndrome, may appear in newborns of mothers who have used quetiapine in the last trimester (last three months of their pregnancy): tremors, muscle stiffness and/or weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and using machines
These tablets may make you feel drowsy. Do not drive or use tools or machines until you know how the tablets affect you.
Effect on drug detection tests in urine
If you are having a urine drug detection test, taking quetiapine may produce positive results for methadone or certain antidepressant medications called tricyclic antidepressants (TCAs) when some analysis methods are used, even if you are not taking methadone or TCAs. If this happens, a more specific test can be performed.
Quetiapine Teva-ratio contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, i.e., it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your disease and needs but will normally be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Elderly patients
If you are an elderly patient, your doctor may change your dose.
Use in children and adolescents
Quetiapine Teva-ratio should not be used in children and adolescents under 18 years of age.
If you take moreQuetiapine Teva-ratiothan you should
If you take more Quetiapine Teva-ratio than your doctor has prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or the nearest hospital immediately. Bring the Quetiapine Teva-ratio tablets with you.
You can also call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.
If you forget to takeQuetiapine Teva-ratio
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed tablet.
If you stop takingQuetiapine Teva-ratio
If you stop taking Quetiapine Teva-ratio abruptly, you may be unable to sleep (insomnia), or you may feel nauseous, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you experience any of the following serious adverse effects, stop taking Quetiapine Teva-ratioand go to your doctor or nearest hospital immediately:
Frequent Adverse Effects(may affect up to 1 in 10 people)
Infrequent Adverse Effects(may affect up to 1 in 100 people)
signs of a very low white blood cell count.
Rare Adverse Effects(may affect up to 1 in 1,000 people)
Very Rare Adverse Effects(may affect up to 1 in 10,000 people)
Unknown Adverse Effects(frequency cannot be estimated from available data)
Drug reaction with eosinophilia and systemic symptoms (DRESS, for its acronym in English). Widespread rash, elevated body temperature, elevated liver enzymes, blood abnormalities (eosinophilia), enlarged lymph nodes, and other organs involved (drug rash with eosinophilia and systemic symptoms, also known as DRESS). If you develop these symptoms, stop using quetiapine and contact your doctor or seek immediate medical attention.
Other Possible Adverse Effects
Do not worry if you see a tablet in your stoolafter taking Quetiapine Teva-ratio. As the tablet passes through your gastrointestinal tract, quetiapine is slowly released. The tablet form remains undissolved and is eliminated in the stool. Therefore, although you may see a tablet in your stool, your dose of quetiapine has been absorbed.
Very Frequent Adverse Effects(may affect more than 1 in 10 people)
Frequent Adverse Effects(may affect up to 1 in 10 people)
Infrequent Adverse Effects(may affect up to 1 in 100 people)
Rare Adverse Effects(may affect up to 1 in 1,000 people)
Very Rare Adverse Effects(may affect up to 1 in 10,000 people)
Unknown(frequency cannot be estimated from available data)
Some adverse effects are only observed when a blood test is performed. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in your blood, increased liver enzymes, decreased red blood cell count, increased creatine phosphokinase in the blood (a substance found in muscles), decreased sodium levels in the blood, and increased prolactin hormone levels in the blood. Increased prolactin levels could, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Adverse Effects in Children and Adolescents
The same adverse effects that can occur in adults can also occur in children and adolescents.
The following adverse effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very Frequent Adverse Effects(may affect more than 1 in 10 people)
Frequent Adverse Effects(may affect up to 1 in 10 people)
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https//www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the packaging and on the blister after CAD. The expiration date is the last day of the month indicated.
Store in the original packaging to protect it from moisture.
Quetiapine Teva-ratio does not require any special storage temperature.
Medicines should not be thrown away through wastewater or household waste. Deposit the packaging and medicines you no longer need in the SIGRE Point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Quetiapine Teva-ratio
The active ingredient is quetiapine. Quetiapine Teva-ratio tablets contain 300 mg of quetiapine (as quetiapine fumarate).
The other ingredients are:
Core of the tablet: hypromellose, microcrystalline cellulose, anhydrous sodium citrate, magnesium stearate.
Coating of the tablet: titanium dioxide (E171), hypromellose, macrogol/PEG 400, polysorbate 80, yellow iron oxide (E172), red iron oxide (E172), and black iron oxide (E172).
Appearance of Quetiapine Teva-ratio and Package Contents
The tablets are light yellow, biconvex, oblong, coated, and engraved with "Q 300" on one side and smooth on the other.
They are available in packages of 10, 20, 30, 50, 50x1 (single-dose perforated blister) (hospital packaging), 56 (calendar packaging), 60, 90, 100, and 100x1 (single-dose perforated blister) tablets.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Teva Pharma, S.L.U.
C/ Anabel Segura 11. Edificio Albatros B, 1ª planta.
28108 Alcobendas. Madrid
Manufacturer
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem
Netherlands
Teva Czech Industries s.r.o.
Ostravska 29, c.p. 305, 74770 Opava-Komarov
Czech Republic
PLIVA Krakow Zaklady Farmaceutyczne S.A.
ul. Mogilska 80. 31-546, Krakow
Poland
Teva Pharma, S.L.U.
C/C, n. 4, Polígono Industrial Malpica, 50016 Zaragoza
Spain
Merckle GmbH
Ludwig-Merckle-Straße 3, 89143 Blaubeuren
Germany
Adamed Pharma S.A
Pienków, ul. Mariana Adamkiewicza 6A
05-152 Czosnów
Poland
Date of the Last Revision of this Prospectus: July 2024
"Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/ "
You can access detailed and updated information about this medicine by scanning the QR code included in the packaging with your mobile phone (smartphone). You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/75281/P_75281.html
The average price of QUETIAPINE TEVA-RATIO 300 mg PROLONGED-RELEASE TABLETS in November, 2025 is around 97.22 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for QUETIAPINE TEVA-RATIO 300 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.